Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
Market Cap | 1.14B |
Revenue (ttm) | 920.59M |
Net Income (ttm) | 108.51M |
Shares Out | n/a |
EPS (ttm) | 0.11 |
PE Ratio | 10.46 |
Forward PE | 8.80 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 2,500 |
Average Volume | 3,141 |
Open | 1.140 |
Previous Close | n/a |
Day's Range | 1.140 - 1.140 |
52-Week Range | 0.931 - 1.430 |
Beta | 0.48 |
RSI | 54.94 |
Earnings Date | Jul 23, 2025 |
About Genomma Lab Internacional
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, anta... [Read more]
Full Company ProfileFinancial Performance
In 2024, Genomma Lab Internacional's revenue was 18.61 billion, an increase of 12.99% compared to the previous year's 16.47 billion. Earnings were 2.09 billion, an increase of 92.74%.
Financial numbers in MXN Financial StatementsNews

Genomma Lab successfully issued the LAB 25 and LAB 25-2 unsecured bonds (Cebures) for a total amount of $1.2 billion pesos, which will be used to prepay liabilities, including the full early amortization of the LAB 23 bond
The 6- and 7-year tranches were oversubscribed by 1.25 times the total amount offered MEXICO CITY , June 4, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or...
Q1 2025 Genomma Lab Internacional SAB de CV Earnings Call Transcript
Q1 2025 Genomma Lab Internacional SAB de CV Earnings Call Transcript

Genomma Lab Internacional Announces Results for the First Quarter 2025
MEXICO CITY , April 30, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2025.

Genomma Lab Internacional S.A.B. de C.V. First Quarter 2025 Earnings Results Conference Call
MEXICO CITY , March 31, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2025 Earnings ...

GENOMMA LAB INTERNACIONAL ANNOUNCES ELEVENTH DIVIDEND PAYMENT
MEXICO CITY , March 6, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

Genomma Lab Internacional Announces Results for the Fourth Quarter and Full Year 2024
MEXICO CITY , Feb. 26, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the fourth quarter and full year ended ...

Genomma Lab Internacional S.A.B. de C.V. Fourth Quarter 2024 Earnings Results Conference Call
MEXICO CITY , Feb. 10, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Fourth Quarter 2024 Earnings ...

Genomma Lab Internacional Announces Results for the Third Quarter 2024
MEXICO CITY , Oct. 23, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2024.

Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2024 Earnings Results Conference Call
MEXICO CITY , Oct. 4, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2024 Earnings Re...

GENOMMA LAB PHARMA MANUFACTURING FACILITY GRANTED PENDING GMP CERTIFICATION FOR THE MEXICAN MARKET
MEXICO CITY , Oct. 2, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies...

GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENT
MEXICO CITY , Sept. 10, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B.

Genomma Lab Announces Strategic Bolt-On Acquisition of Four Brands
MEXICO CITY, July 25, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

Genomma Lab Internacional Announces Results for the Second Quarter 2024
MEXICO CITY , July 24, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the second quarter of 2024.

GENOMMA LAB ANNOUNCES REFINANCING OF LONG-TERM LIABILITIES AND RELEASE OF REAL ESTATE COLLATERAL
MEXICO CITY , July 22, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V . (BMV: LABB) ("Genomma Lab" or "the Company"), a leading company in the pharmaceutical and personal care industry ...

Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2024 Earnings Results Conference Call
MEXICO CITY , July 2, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Second Quarter 2024 Earnings R...

GENOMMA LAB INTERNACIONAL ANNOUNCES EIGHTH DIVIDEND PAYMENT
MEXICO CITY , June 13, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

Genomma Lab Internacional Announces Results for the First Quarter 2024
MEXICO CITY , April 24, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024.

Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call
MEXICO CITY , April 4, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2024 Earnings R...

GENOMMA LAB INTERNACIONAL ANNOUNCES SEVENTH DIVIDEND PAYMENT
MEXICO CITY , March 13, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product compani...

Genomma Lab's ESG Rating Upgraded to A
Reflects Third Consecutive Rating Improvement in Four Years MEXICO CITY , Feb. 28, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of t...

Genomma Lab Internacional Reports Fourth Quarter & Full Year 2023 Results
"Due to the abrupt devaluation of the Argentine peso in late December, accounting rules required Genomma Lab to record a non-cash negative impact on 4Q23 and full year 2023 earnings. However, excludin...

Genomma Lab Internacional S.A.B. de C.V. Fourth Quarter and Full Year 2023 Earnings Results Conference Call
MEXICO CITY , Jan. 23, 2024 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Fourth Quarter and Full Year ...

GENOMMA LAB INTERNACIONAL ANNOUNCES SIXTH DIVIDEND PAYMENT
MEXICO CITY , Dec. 13, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companie...

Genomma Lab Internacional Reports Third Quarter 2023 Results
MEXICO CITY , Oct. 25, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the third quarter ended September 3...

Genomma Lab Internacional S.A.B. de C.V. Third Quarter 2023 Earnings Results Conference Call
MEXICO CITY , Oct. 4, 2023 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2023 results on ...